ENG

Company News

HSA grants PSAR for Rapigen's BIOCREDIT COVID-19 Ag Home Test Nasal

Date 2022.03.05 Hit 1891

As of 23 February 2022, Singapore Health Sciences Authority (HSA) has authorized BIOCREDIT COVID-19 OTC self-test kits for use in Singapore.
 

Rapigen's BIOCREDIT COVID-19 Ag Home Test Nasal kits will be available in stores from March amid Singapore logging a record high of 18,162 new Covid-19 cases on March 3, a total of 785,825 accumulated cases thus far.

  

For self-tests that have been authorized by HSA under PSAR, please visit :

https://www.hsa.gov.sg/consumer-safety/articles/covid19_selftests 

 

(*PSAR : Pandemic Special Access Route)


      




 



목록보기